Method of treating IgG4-related disease
OwnerJason Kihyuk Leeinventor
Life of this patent
Estimating the term…
Abstract
This patent relates to a method of treating IgG4-related disease comprising administration of an Interleukin-4 inhibitor/antagonist, an IL-4 receptor alpha inhibitor, or a compound which blocks assembly of IL-4 receptor alpha with IL-13 receptor alpha. The method of treating IgG4-related disease may comprise administration of a JAK inhibitor. The method of treating IgG4-related disease may comprise administration of duplimab and/or pitrakinra.
Claims5
Method of treating IgG4-Related Disease (RD) selected from the group consisting of IgG4-associated asthma, atopic dermatitis, organ sclerosis (including sclerosing pancreatitis), cholangitis, and organ fibrosis, in a patient in need thereof comprising administering an effective amount of dupilumab or a pharmaceutically acceptable salt thereof, wherein the IgG4-Related Disease is treated or the effects of the disease are diminished by said effective amount.
Dependencies are inferred from the claim text.